Michael Luo

Vibex QST - The True Blockbuster In The Antares Pharma Pipeline

Vibex QST - The True Blockbuster In The Antares Pharma Pipeline

My last article on Antares Pharma (NASDAQ:ATRS) focused on Otrexup approval and how it would transform Antares into a true proprietary product based biotech with growing earnings per share. The natural progression would be to show the investing public on why a successful Otrexup launch and commercialization will be able to fund the true blockbuster in the pipeline - Vibex QST. Vibex QST was briefly mentioned in my first article. This article outlines my investment thesis on why Vibex QST is the true gem in the pipeline and how it will be the dominant player in a $5B market in the next couple of years.

Updates on

Join Seeking Alpha PRO to read this archived article and 11,574 other archived articles
FREESA PRO MEMBERS
IDEA GENERATORXExclusive access to 10 PRO ideas every day
INVESTING IDEAS LIBRARYXExclusive access to PRO library of more than 15,000 ideas
SECTOR EXPERT NETWORKXExclusive access to all sector experts for direct consultation
PERFORMANCE TRACKINGXTrack performance of all PRO stock ideas
PROFESSIONAL TOOLSXProfessional Idea Filters to zero-in based on industry, market cap and more
"In just the first month of using PRO, I used it to generate two ideas which were actionable for me. As a result of these two positions, I have earned more than 20 times the annual subscription costs for PRO."Michael Yagemann, Greenbridge Capital
"I am pleasantly surprised with the scope of small and mid-cap coverage PRO offers. You can't find that any where else."Patrick Rice, Mainstay Capital Management
You may cancel at any time for any reason, and receive a prompt refund for membership on months paid and not used (max. 6 months). Details